Prostaglandin E2 synthesis and metabolism in burn injury and trauma

Journal of Trauma - Injury, Infection and Critical Care

Volumn 49, Issue 6, 2000, Pages 1147-1154

  Hahn, Elisabeth L ^a   He, Li Ke ^a   Gamelli, Richard L ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2;

BURN; IMMUNE SYSTEM; INFECTION; METABOLIC REGULATION; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SEPSIS; BIOSYNTHESIS; HUMAN; PATHOPHYSIOLOGY;

BURNS; DINOPROSTONE; HUMANS; SEPSIS;

EID: 0034527022     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005373-200012000-00033     Document Type: Review

References (84)

1. Prostaglandin D, E, and F syntheses
2. Physiological and pathophysiological roles of eicosanoids in the microcirculation
3. Molecular regulation of prostaglandin synthesis. Implications for endocrine systems
4. Cyclooxygenase-dependent signaling: Molecular events and consequences
5. Molecular mechanisms of prostaglandin transport
6. Pulmonary circulation and burns and trauma
7. Plasma cytokine levels in patients with severe bum injury - With reference to the relationship between infection and prognosis
8. Burn wound infections: Current status
9. Molecular mechanisms regulating prostaglandin action
10. 2 and nitrite/nitrate in patients with burns
11. 2, cytokines and eicosanoids in patients with burns
12. 2, PAF acetylhydrolase, endothelin 1, and thrombomodulin in patients with infected bums
13. Prognostic impact of preclinically evaluated inflammatory mediators in polytrauma
14. Prostanoid receptors of murine NIH 3T3 and RAW 264.7 cells - Structure and expression of the murine prostaglandin EP4 receptor gene
15. The role of cyclooxygenases in inflammation, cancer, and development
16. Molecular pathology of cyclooxygenase-2 in neoplasia
17. 2 production in severely injured patients
18. 2 by macrophages isolated after thermal injury and bacterial translocation
19. 2 and cytotoxicity of IL-1 stimulated bone marrow macrophages after thermal injury and cytotoxicity of stimulated U-937 macrophages
20. Cyclooxygenase 2 (COX-2) gene activation is regulated by cyclic adenosine monophosphate
21. Regulation of macrophage eicosanoid generation is dependent on nuclear factor kappa-b
22. 2 by LPS-stimulated rat bone marrow macrophages after thermal injury: Effect of indomethacin
23. 2 by isolated enterocytes and gut macrophages: Effect of lipopolysaccharide and thermal injury
24. Role of thromboxane, prostaglandins and leukotrienes in endotoxic and septic shock
25. Interaction of eicosanoids and macrophages during inflammatory responses
26. Update on the mechanisms of immune suppression of injury and immune modulation
27. Evidence for Kupffer cell activation by burn injury and Pseudomonas exotoxin A
28. Thermal injury induces the development of inflammatory macrophages from nonadherent bone marrow cells
29. 2 and immunomodulation with indomethacin
30. ABT-299, a novel PAF antagonist, attenuates multiple effects of endotoxemia in conscious rats
31. Map kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes
32. Free radical activity and loss of plasma antioxidants, vitamin E, and sulfhydryl groups in patients with burns: The 1993 Moyer Award
33. 2) differentially regulates the production of IL-2 and IL-3 by murine immune T-cells
34. 2 modulation of p59(fyn) tyrosine kinase in T lymphocytes during sepsis
35. Thermal injury alters macrophage responses to prostaglandin E-2: Contribution to the enhancement of inducible nitric oxide synthase activity
36. Effect of burn injury on granulocyte and macrophage production
37. Cyclooxygenase-2 inhibitor NS-398 improves survival and restores leukocyte counts in burn infection
38. 2, elevated adenylate cyclase, and cyclic adenosine monophosphate
39. Prostaglandin metabolism, synthesis, and blockade in hemorrhage and sepsis
40. Effect of PGE in multiple experimental models. IX: In vivo effects of PGE on immune response of leukocytes to wounds
41. Effect of ibuprofen on the inflammatory response to surgical wounds
42. Blockade of prostaglandin products augments macrophage and neutrophil tumor necrosis factor synthesis in burn injury
43. Effect of thermal injury and sepsis on neutrophil function
44. Ibuprofen therapy in experimental porcine gram-negative septic shock
45. 2 production
46. Ibuprofen intervention in canine septic shock: Reduction of pathophysiology without decreased cytokines
47. The effects of ibuprofen on the physiology and survival of patients with sepsis
48. 2 biosynthesis in cyclooxygenase 1 or 2 null cells
49. Treating patients with severe sepsis
50. Importance and nature of the mechanism of inactivation of prostaglandins in the lung
51. 15-hydroxyprostaglandin dehydrogenase. A review
52. On the metabolism of prostaglandins E 1 and E 2 in man
53. Prostaglandin-metabolizing enzymes during pregnancy: Characterization of 3 NAD(+)-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omega-hydroxylase
54. Prostaglandin 9-ketoreductase/type II 15-hydroxyprostaglandin dehydrogenase is not a prostaglandin specific enzyme
55. Prostaglandin 9-ketoreductase and type II 15-hydroxyprostaglandin dehydrogenase from swine kidney are alternate activities of a single enzyme protein
56. Comparison of substrate specificities of the human placental NAD- and NADP-linked 15-hydroxyprostaglandin dehydrogenases
57. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from porcine kidney. II. Kinetic studies
58. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase from porcine kidney. I. Purification and partial characterization
59. NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase: Immunochemical characterization of the lung enzyme from pregnant rabbits
60. Immunocytochemical distribution and localization of 15-hydroxyprostaglandin dehydrogenase in human fetal membranes, decidua, and placenta
61. Localization of S-hydroxy prostaglandin dehydrogenase in human fetal membranes, decidua, and placenta during pregnancy
62. Inhibition of 15-hydroxyprostaglandin dehydrogenase activity in rabbit gastric antral mucosa by panaxynol isolated from oriental medicines
63. Enhancement of experimental colon cancer by genistein
64. Cysteine 182 is essential for enzymatic activity of human placental NAD(+) dependent 15-hydroxyprostaglandin dehydrogenase
65. 15-Hydroxyprostaglandin dehydrogenase
66. Immunohistochemical localization, messenger ribonucleic acid abundance, and activity of 15-hydroxyprostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labor
67. Rapid reduction of prostaglandin 15-hydroxy dehydrogenase activity in rat tissues after treatment with protein synthesis inhibitors
68. Prostaglandin 15-hydroxydehydrogenase activity during pregnancy in rabbits and rats
69. Progesterone and estrogen control of uterine prostaglandin dehydrogenase activity during decidual growth
70. Sex differences in prostaglandin metabolism
71. The influence of environmental agents on prostaglandin biosynthesis and metabolism in the lung. Inhibition of lung 15-hydroxyprostaglandin dehydrogenase by exposure of guinea pigs to 100 per cent oxygen at atmospheric pressure
72. The effects of vitamin E depletion and repletion on prostaglandin dehydrogenase activity in tissues of young rabbits
73. Effect of dietary vitamin E or selenium on prostaglandin dehydrogenase in hyperoxic rat lung
74. 1 metabolism
75. New inhibitor(s) of 15-hydroxyprostaglandin dehydrogenase in human milk
76. 15-hydroxy prostaglandin dehydrogenase: Implications in preterm labor with and without ascending infection
77. 2 alterations during sepsis are partially mediated by endotoxin-induced inhibition of prostaglandin 15-hydroxydehydrogenase
78. Burn injury with infection alters prostaglandin metabolism
79. Characterization of the genomic structure and promoter of the mouse NAD+-dependent 15-hydroxyprostaglandin dehydrogenase gene
80. Cloning and expression of the cDNA for rat NAD+-dependent 15-hydroxyprostaglandin dehydrogenase
81. Cloning and expression of the cDNA for mouse NAD(+)dependent 15-hydroxyprostaglandin dehydrogenase
82. Cloning and sequence analysis of the cDNA for human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase
83. Cyclooxygenase knockout mice: Models for elucidating isoform-specific functions
84. Inducible cyclooxygenase may have anti-inflammatory properties